Cargando…
How (not) to mobilize health workers in the fight against vaccine hesitancy: Experimental evidence from Germany’s AstraZeneca controversy
BACKGROUND: COVID-19 vaccine hesistancy is a serious policy issue in Germany as vaccinations have stagnated at low levels compared to most other European countries. In this context, we study whether and how health workers can be leveraged to promote the COVID-19 vaccination campaign. METHODS: We emp...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8926095/ https://www.ncbi.nlm.nih.gov/pubmed/35296289 http://dx.doi.org/10.1186/s12889-022-12725-9 |
_version_ | 1784670163601195008 |
---|---|
author | Priebe, Jan Silber, Henning Beuthner, Christoph Pötzschke, Steffen |
author_facet | Priebe, Jan Silber, Henning Beuthner, Christoph Pötzschke, Steffen |
author_sort | Priebe, Jan |
collection | PubMed |
description | BACKGROUND: COVID-19 vaccine hesistancy is a serious policy issue in Germany as vaccinations have stagnated at low levels compared to most other European countries. In this context, we study whether and how health workers can be leveraged to promote the COVID-19 vaccination campaign. METHODS: We employed an information experiment with health workers in Germany to quantify how access to information related to (i) AstraZeneca’s vaccine safety, (ii) misinformation, (iii) individual health risks, and (iv) public health risks can sway health workers’ recommendations for any of the following vaccines: AstraZeneca, Johnson & Johnson, Moderna, Pfizer/BioNTech, Sinopharm, and Sputnik-V. The information experiment was conducted as a randomized controlled trial with four treatment arms and was embedded in an online survey. RESULTS: Health workers reduce their willingness to recommend four out of six vaccines once they learn about different statements of European and German health authorities with respect to the safety of the AstraZeneca vaccine. Consistent with the discussion on AstraZeneca’s safety focusing on possible side effects among younger women, we find that especially female health workers become less likely to recommend the majority of COVID-19 vaccines. Lastly, we show that health workers vaccine recommendations are not affected by misinformation and appeals to individual or public health. CONCLUSION: In order to mobilize health workers in the fight against vaccine hesitancy, information campaigns need to be tailor-made for the target audience. In particular, health workers react to different types of information than the general public. As with the general public, we provide suggestive evidence that health workers require unambigious messages from drug authorities in order to support vaccination efforts. We believe that a more coordinated and coherent approach of public authorities can reduce the amount of mixed signals that health workers receive and therefore contribute to health workers engagement in the outroll of mass COVID-19 vaccination campaigns. TRIAL REGISTRATION: The trial was registered retrospectively with the repository of the Open Science Framework (OSF) under the number osf.io/qa4n2. |
format | Online Article Text |
id | pubmed-8926095 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-89260952022-03-17 How (not) to mobilize health workers in the fight against vaccine hesitancy: Experimental evidence from Germany’s AstraZeneca controversy Priebe, Jan Silber, Henning Beuthner, Christoph Pötzschke, Steffen BMC Public Health Research BACKGROUND: COVID-19 vaccine hesistancy is a serious policy issue in Germany as vaccinations have stagnated at low levels compared to most other European countries. In this context, we study whether and how health workers can be leveraged to promote the COVID-19 vaccination campaign. METHODS: We employed an information experiment with health workers in Germany to quantify how access to information related to (i) AstraZeneca’s vaccine safety, (ii) misinformation, (iii) individual health risks, and (iv) public health risks can sway health workers’ recommendations for any of the following vaccines: AstraZeneca, Johnson & Johnson, Moderna, Pfizer/BioNTech, Sinopharm, and Sputnik-V. The information experiment was conducted as a randomized controlled trial with four treatment arms and was embedded in an online survey. RESULTS: Health workers reduce their willingness to recommend four out of six vaccines once they learn about different statements of European and German health authorities with respect to the safety of the AstraZeneca vaccine. Consistent with the discussion on AstraZeneca’s safety focusing on possible side effects among younger women, we find that especially female health workers become less likely to recommend the majority of COVID-19 vaccines. Lastly, we show that health workers vaccine recommendations are not affected by misinformation and appeals to individual or public health. CONCLUSION: In order to mobilize health workers in the fight against vaccine hesitancy, information campaigns need to be tailor-made for the target audience. In particular, health workers react to different types of information than the general public. As with the general public, we provide suggestive evidence that health workers require unambigious messages from drug authorities in order to support vaccination efforts. We believe that a more coordinated and coherent approach of public authorities can reduce the amount of mixed signals that health workers receive and therefore contribute to health workers engagement in the outroll of mass COVID-19 vaccination campaigns. TRIAL REGISTRATION: The trial was registered retrospectively with the repository of the Open Science Framework (OSF) under the number osf.io/qa4n2. BioMed Central 2022-03-16 /pmc/articles/PMC8926095/ /pubmed/35296289 http://dx.doi.org/10.1186/s12889-022-12725-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visithttp://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Priebe, Jan Silber, Henning Beuthner, Christoph Pötzschke, Steffen How (not) to mobilize health workers in the fight against vaccine hesitancy: Experimental evidence from Germany’s AstraZeneca controversy |
title | How (not) to mobilize health workers in the fight against vaccine hesitancy: Experimental evidence from Germany’s AstraZeneca controversy |
title_full | How (not) to mobilize health workers in the fight against vaccine hesitancy: Experimental evidence from Germany’s AstraZeneca controversy |
title_fullStr | How (not) to mobilize health workers in the fight against vaccine hesitancy: Experimental evidence from Germany’s AstraZeneca controversy |
title_full_unstemmed | How (not) to mobilize health workers in the fight against vaccine hesitancy: Experimental evidence from Germany’s AstraZeneca controversy |
title_short | How (not) to mobilize health workers in the fight against vaccine hesitancy: Experimental evidence from Germany’s AstraZeneca controversy |
title_sort | how (not) to mobilize health workers in the fight against vaccine hesitancy: experimental evidence from germany’s astrazeneca controversy |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8926095/ https://www.ncbi.nlm.nih.gov/pubmed/35296289 http://dx.doi.org/10.1186/s12889-022-12725-9 |
work_keys_str_mv | AT priebejan hownottomobilizehealthworkersinthefightagainstvaccinehesitancyexperimentalevidencefromgermanysastrazenecacontroversy AT silberhenning hownottomobilizehealthworkersinthefightagainstvaccinehesitancyexperimentalevidencefromgermanysastrazenecacontroversy AT beuthnerchristoph hownottomobilizehealthworkersinthefightagainstvaccinehesitancyexperimentalevidencefromgermanysastrazenecacontroversy AT potzschkesteffen hownottomobilizehealthworkersinthefightagainstvaccinehesitancyexperimentalevidencefromgermanysastrazenecacontroversy |